Download the Poster:

Optimizing Cell Therapy with IntegriCell™ Automated Cryopreservation

Discover how IntegriCell™ Enhances Quality and Consistency in Cell-Based Therapies

Cryoport Systems, the global leader in temperature-controlled supply chain solutions, recently presented a poster on the development of an automated cryopreservation process for leukapheresis through our IntegriCell™ platform.

Learn how the IntegriCell™ platform optimizes cryopreservation with automated closed processing, maintaining cell viability and recovery across multiple donor-derived leukaphereses.

By providing high-quality, manufacture-ready cryopreserved leukopaks for cell therapy manufacturing, IntegriCell™ supports increased standardization and reliability. Our process offers exceptional consistency batch-to-batch, increasing the reliability of cryopreserved leukopaks. Dive into the details of our GMP-compatible automated cryopreservation service and discover how Cryoport Systems is enhancing the cell therapy supply chain for clinical and commercial partners globally.

Fill out the form to access the full poster.

Innovations in cell therapy? That’s your mission.
Preserving and delivering critical cell materials?
That’s our promise.

Let’s advance the future of patient care, together.